PACTR201701001940111尚未招募未知
Safety of ziv-aflibercept in retinal diseases in a Ghanaian population.
Imoro Zeba braimah0 个研究点目标入组 20 人开始时间: 2016年12月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Year(s) 至 85 Year(s)（—）
- 性别
- All
入选标准
- •Age 18 years or older
- •Meets diagnostic criteria for DM, RVO and active nvAMD (Appendix I)
- •Treatment naïve
- •Understands and willing to sign consent form
- •Able to comply with clinic visits
- •Centre involving ME in patients with diabetes mellitus and RVO with retinal thickness >300um using SD- OCT
- •BCVA of 6/12 or worse
排除标准
- •Glaucoma or raised intraocular pressure (>21mmHg)
- •Intraocular surgery within 3 months in the study eye
- •History of uveitis
- •Pregnant or breastfeeding mother
- •Renal failure on dialysis or had kidney transplant
- •Allergy to active drug or excipients
- •Cardiovascular events such as myocardial infarction or CVA
- •Eye infections such blepharitis, dacryocystitis, conjunctivitis or keratitis.
- •Unwilling to sign consent form or to come for follow up visits
- •Myopia ¿-6.0 Dioptres
研究者
相似试验
终止
3 期
Efficacy and safety of intravitreal Ziv-aflibercept injection for the treatment of refractory diabetic macula edemaDiabetic macular edemaDiabetes mellitusDiabetic macular edemaOphthalmic complications of diabetes mellitusZiv-afliberceptBevacizumabintravitreal injectionanti-vascular endothelial growth factorsTCTR20191130001Faculty of Medicine, Khon Kaen University7
尚未招募
不适用
Safety and efficacy of ziv Aflibercept compounding in refractory diabetic macular oedemaACTRN12616000012471Dr Andrew Riley40
已完成
1 期
Use of Ziv Aflibercept in Different Retinal DiseasesCentral Retinal Vein Occlusion With Macular EdemaNCT04290195Amin El Sayed Nawar55
Unknown
2 期
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF InjectionNeovascularizationRetinal NeovascularizationRecurrent PterygiumDiabetic RetinopathyMacular DegenerationCystoid Macular EdemaChoroidal NeovascularizationRetinal Vein OcclusionNCT02486484Rafic Hariri University Hospital100
已完成
不适用
Aflibercept in Patients With Pigment Epithelial Detachments (PED)Pigment Epithelial DetachmentNCT03370380University Hospital Muenster18